Title : Phase II evaluation of recombinant interferon-beta (IFN-beta ser) in patients with diffuse mesothelioma: a Southwest Oncology Group study.

Pub. Date : 1990 Oct

PMID : 2273299






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 IFN-beta ser at this dose and schedule does not appear to be an active single agent for patients with refractory malignant mesothelioma. Serine interferon beta 1 Homo sapiens